Amyloid β protein agglutination-controlling factor
View Patent ↗The present invention provides: proteins suppressing or promoting the aggregation or deposition of amyloid-β protein; polynucleotides encoding the proteins; a method for screening a compound suppressing or promoting the aggregation or deposition of amyloid-β protein; and therapeutic agents for treating or preventing Alzheimer's diseases comprising a compound that regulates the activity of a protein suppressing or promoting the aggregation or deposition of amyloid-β protein.
1. An isolated polynucleotide selected from the group consisting of:
(a) a polynucleotide that comprises a nucleotide sequence as set forth in SEQ ID NO:3, 5, 7 or 9,
(b) a polynucleotide that encodes a polypeptide having an amino acid sequence as set forth in SEQ ID NO: 4, 6, 8 or 10,
(c) a polynucleotide that hybridizes under stringent conditions to a polynucleotide comprising a nucleotide sequence as set forth in SEQ ID NO: 3, 5, 7 or 9, wherein the stringent conditions comprise washing in 0.1×SSC and 0.1% SDS at 65° C., and
(d) a polynucleotide that shows at least 95% identity to a nucleotide sequence as set forth in SEQ ID NO: 3, 5, 7 or 9, or a fragment of said polynucleotide;
wherein said polynucleotide or said polynucleotide fragment encodes a polypeptide (a) which suppresses or promotes the aggregation of amyloid or (b) which is an immunogenic polypeptide.
2. The polynucleotide of claim 1 which comprises SEQ ID NO: 3.
3. The polynucleotide of claim 1 which comprises SEQ ID NO: 5.
4. The polynucleotide of claim 1 which comprises SEQ ID NO: 7.
5. The polynucleotide of claim 1 which comprises SEQ ID NO: 9.
6. The polynucleotide of claim 1 which encodes a protein having the amino acid sequence set forth in SEQ ID NO: 4.
7. The polynucleotide of claim 1 which encodes a protein having the amino acid sequence set forth in SEQ ID NO: 6.
8. The polynucleotide of claim 1 which encodes a protein having the amino acid sequence set forth in SEQ ID NO: 8.
9. The polynucleotide of claim 1 encodes a protein having the amino acid sequence set forth in SEQ ID NO: 10.
10. The polynucleotide of claim 1 which is a polynucleotide that hybridizes under stringent conditions to a polynucleotide comprising a nucleotide sequence as set forth in SEQ ID NO: 3, 5, 7 or 9, wherein the stringent conditions comprise washing in 0.1×SSC and 0.1% SDS at 65° C.
11. The polynucleotide of claim 1 which is a polynucleotide that shows at least 95% identity to a nucleotide sequence as set forth in SEQ ID NO: 3, 5, 7 or 9.
12. An isolated fragment of the polynucleotide of claim 1 ,
wherein said polynucleotide fragment encodes a polypeptide (a) which suppresses or promotes the aggregation of amyloid or (b) which is an immunogenic polypeptide.
13. The polynucleotide of claim 1 which encodes a polypeptide which suppresses the aggregation of amyloid.
14. The polynucleotide of claim 1 , which encodes a polypeptide which promotes the aggregation of amyloid.
15. The polynucleotide of claim 1 , which encodes an immunogenic polypeptide.
16. A vector comprising the polynucleotide of claim 1 .
17. The vector of claim 15 which is an expression vector.
18. A transfected host cell comprising the polynucleotide of claim 1 .
19. The transfected host cell of claim 18 which is a prokaryotic cell.
20. The transfected host cell of claim 18 which is Escherichia coli.
21. The transfected host cell of claim 18 which is a eukaryotic cell.
22. The transfected host cell of claim 18 , which is selected from the group consisting of S. cerevisiae , an HEK293 cell, a murine L929 cells, and a CHO cell.
23. A transfected host cell comprising the vector of claim 16 .
24. A method for making a polypeptide comprising:
expressing the polynucleotide of claim 1 under conditions suitable for expression of the polypeptide that it encodes, and
recovering the polypeptide.
25. A method for detecting Alzheimer's disease, comprising:
(a) measuring the expression of a polynucleotide according to claim 1 ,
(b) comparing the measurement obtained in (a) with that obtained when the polynucleotide is expressed in healthy subjects and detecting a change in expression, and
(c) linking Alzheimer's disease with said change in expression of the polynucleotide.
26. A method of screening for a compound that regulates expression of a peptide encoded by a polynucleotide according to claim 1 , comprising:
(a) contacting a candidate compound with a cell, wherein a vector has been introduced into said cell, said vector comprising:
(i) an expression regulatory region of a gene comprising a nucleotide sequence selected from the group consisting of SEQ ID NO. 3, SEQ ID NO. 5, SEQ ID NO. 7, and SEQ ID NO. 9, and,
(ii) a reporter gene operably linked downstream of the expression regulatory region,
(b) measuring the presence of the reporter gene, and,
(c) selecting the candidate compound that increases or decreases the reporter activity measured in step (b) when compared to the control.
27. A composition comprising the isolated polynucleotide of claim 1 and a pharmaceutically acceptable carrier or vehicle.